MeSH term
Frequency | Condition_Probility | Animals | 109 | 0.0 |
Binding Sites | 41 | 0.0 |
DNA/metabolism | 15 | 1.0 |
Electrophoresis, Polyacrylamide Gel | 7 | 0.0 |
*Gene Expression Regulation | 13 | 0.0 |
Homeodomain Proteins/genetics/*metabolism | 4 | 2.0 |
Humans | 151 | 0.0 |
Mice | 55 | 0.0 |
Promoter Regions (Genetics) | 31 | 0.0 |
Research Support, Non-U.S. Gov't | 129 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 14 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 85 | 0.0 |
Serum Response Factor/*metabolism | 11 | 84.0 |
*Transcription Factors | 13 | 0.0 |
Transfection | 36 | 0.0 |
*Xenopus Proteins | 8 | 2.0 |
Amino Acid Sequence | 46 | 0.0 |
Cell Nucleus/metabolism | 12 | 0.0 |
Hela Cells | 40 | 0.0 |
Macromolecular Substances | 6 | 0.0 |
Molecular Sequence Data | 90 | 0.0 |
Mutation | 12 | 0.0 |
NF-kappa B/metabolism | 3 | 0.0 |
Phenotype | 7 | 0.0 |
Serum Response Factor/metabolism | 5 | 55.0 |
Trans-Activation (Genetics) | 15 | 0.0 |
Transcription Factor AP-1/metabolism | 2 | 0.0 |
Actins/genetics | 5 | 3.0 |
Base Sequence | 82 | 0.0 |
Cells, Cultured | 29 | 0.0 |
DNA-Binding Proteins/chemistry/*metabolism | 2 | 1.0 |
Glutathione Transferase/metabolism | 4 | 0.0 |
Myocardium/*metabolism | 9 | 3.0 |
Neurons/metabolism | 2 | 0.0 |
*Nuclear Proteins | 4 | 0.0 |
Precipitin Tests | 3 | 0.0 |
*Promoter Regions (Genetics) | 17 | 0.0 |
Protein Binding | 22 | 0.0 |
Protein Structure, Tertiary | 11 | 0.0 |
Rats | 21 | 0.0 |
Rats, Sprague-Dawley | 4 | 0.0 |
Two-Hybrid System Techniques | 3 | 0.0 |
Cell Division/drug effects | 4 | 0.0 |
Chromones/pharmacology | 2 | 0.0 |
*DNA-Binding Proteins | 4 | 0.0 |
Enzyme Inhibitors/pharmacology | 7 | 0.0 |
Female | 9 | 0.0 |
Gene Expression Regulation, Neoplastic/*drug effects | 2 | 0.0 |
Genes, Reporter | 13 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 6 | 0.0 |
Morpholines/pharmacology | 2 | 0.0 |
Phosphorylation/drug effects | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 7 | 0.0 |
Tumor Cells, Cultured | 12 | 0.0 |
Adult | 4 | 0.0 |
Aged | 2 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Comparative Study | 19 | 0.0 |
Male | 9 | 0.0 |
Middle Aged | 4 | 0.0 |
Reproducibility of Results | 2 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Cell Line | 25 | 0.0 |
Chick Embryo | 3 | 0.0 |
DNA-Binding Proteins/*metabolism | 24 | 1.0 |
Heart/*embryology | 2 | 3.0 |
Homeodomain Proteins/*metabolism | 5 | 3.0 |
Transcription Factors/*metabolism | 20 | 1.0 |
Cloning, Molecular | 18 | 0.0 |
Conserved Sequence | 7 | 0.0 |
Embryo | 2 | 0.0 |
GTPase-Activating Proteins/*metabolism | 2 | 8.0 |
Gene Library | 3 | 0.0 |
Muscle, Skeletal/*metabolism | 4 | 2.0 |
Sequence Alignment | 15 | 0.0 |
Sequence Homology, Amino Acid | 14 | 0.0 |
Sequence Homology, Nucleic Acid | 11 | 0.0 |
Transcription Factors/chemistry/*genetics/*metabolism | 2 | 7.0 |
*Transcription, Genetic | 15 | 0.0 |
*Alternative Splicing | 2 | 0.0 |
Cell Division | 6 | 0.0 |
DNA Primers | 5 | 0.0 |
DNA Probes | 5 | 0.0 |
Exons | 2 | 0.0 |
Gene Expression Regulation | 15 | 0.0 |
Protein Isoforms/genetics | 3 | 1.0 |
Rabbits | 5 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Serum Response Factor/*genetics | 5 | 83.0 |
Transcription, Genetic | 25 | 0.0 |
*Genes, fos | 8 | 12.0 |
Jurkat Cells | 4 | 0.0 |
Luciferases/genetics | 3 | 0.0 |
Lymphocyte Activation | 2 | 0.0 |
*MAP Kinase Kinase Kinase 1 | 2 | 1.0 |
Phosphorylation | 20 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 6 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 3 | 0.0 |
Recombinant Fusion Proteins/metabolism | 11 | 0.0 |
Serum Response Factor/genetics/*metabolism | 5 | 100.0 |
p38 Mitogen-Activated Protein Kinases | 2 | 0.0 |
Crystallography, X-Ray | 2 | 0.0 |
DNA-Binding Proteins/*chemistry/*metabolism | 4 | 6.0 |
Models, Molecular | 7 | 0.0 |
Nucleic Acid Conformation | 4 | 0.0 |
Promoter Regions (Genetics)/genetics | 11 | 1.0 |
Proto-Oncogene Proteins/chemistry/metabolism | 2 | 13.0 |
Response Elements/genetics | 4 | 2.0 |
Cell Differentiation | 8 | 0.0 |
Cell Proliferation | 2 | 1.0 |
DNA-Binding Proteins/metabolism | 13 | 0.0 |
*Gene Expression | 2 | 0.0 |
Nuclear Proteins/*metabolism | 27 | 3.0 |
Trans-Activators/*metabolism | 2 | 0.0 |
Signal Transduction/physiology | 4 | 0.0 |
Models, Genetic | 5 | 0.0 |
Serum Response Factor | 80 | 72.0 |
*Trans-Activation (Genetics) | 14 | 1.0 |
Trans-Activators/*physiology | 2 | 0.0 |
Transcription Factors/*physiology | 7 | 1.0 |
RNA Interference | 2 | 0.0 |
DNA/*chemistry/metabolism | 3 | 12.0 |
Protein Structure, Secondary | 3 | 0.0 |
Regulatory Sequences, Nucleic Acid | 9 | 1.0 |
Apoptosis | 2 | 0.0 |
Cell Survival | 3 | 0.0 |
Actins/*genetics | 11 | 17.0 |
Aging | 3 | 0.0 |
Atrial Natriuretic Factor/genetics | 2 | 20.0 |
Blotting, Northern | 5 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 13 | 1.0 |
*Gene Expression Regulation, Developmental | 4 | 0.0 |
Genes, fos | 6 | 5.0 |
Mice, Transgenic | 6 | 0.0 |
Myocardium/*metabolism/pathology | 2 | 7.0 |
Myosin Heavy Chains/*genetics | 2 | 5.0 |
Nuclear Proteins/genetics/*metabolism | 7 | 2.0 |
Transcription Factors/genetics/metabolism | 6 | 1.0 |
Blotting, Western | 13 | 0.0 |
*Cell Aging | 4 | 7.0 |
Cell Lineage | 2 | 0.0 |
Cell Nucleus/*metabolism | 4 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Muscle, Smooth/metabolism | 4 | 7.0 |
Nuclear Proteins/metabolism | 7 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Signal Transduction | 9 | 0.0 |
Time Factors | 6 | 0.0 |
Trans-Activators/metabolism | 3 | 0.0 |
Escherichia coli | 2 | 0.0 |
Gene Expression | 10 | 0.0 |
Glutathione Transferase/genetics | 2 | 0.0 |
Peptide Fragments/chemistry/metabolism | 2 | 1.0 |
Plasmids/genetics | 4 | 0.0 |
Structure-Activity Relationship | 6 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Myocardium/metabolism | 7 | 2.0 |
Nuclear Proteins/*chemistry/*metabolism | 2 | 9.0 |
Transcription Factors/*chemistry/*metabolism | 2 | 5.0 |
COS Cells | 9 | 0.0 |
Plasmids/metabolism | 3 | 0.0 |
Protein Isoforms | 2 | 0.0 |
Bacterial Proteins/metabolism | 2 | 3.0 |
Binding Sites/genetics | 6 | 0.0 |
Proto-Oncogene Proteins c-fos/*metabolism | 2 | 5.0 |
Chromosome Mapping | 6 | 0.0 |
DNA | 4 | 0.0 |
RNA, Messenger/genetics | 6 | 0.0 |
DNA-Binding Proteins/*genetics | 9 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Fetus | 2 | 0.0 |
Muscle Proteins/genetics/metabolism | 2 | 11.0 |
Nuclear Proteins/*genetics | 7 | 1.0 |
RNA/genetics/metabolism | 2 | 1.0 |
Cell Aging/*physiology | 2 | 3.0 |
*Genes, Immediate-Early | 2 | 6.0 |
Gene Transfer Techniques | 2 | 0.0 |
Muscles/metabolism | 2 | 2.0 |
Point Mutation | 6 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/metabolism | 2 | 1.0 |
DNA-Binding Proteins/*physiology | 10 | 1.0 |
Gene Products, tax/*physiology | 4 | 20.0 |
Human T-lymphotropic virus 1/*genetics | 5 | 9.0 |
Nuclear Proteins/*physiology | 8 | 5.0 |
Animals, Newborn | 4 | 0.0 |
Organ Specificity | 5 | 0.0 |
Recombinant Fusion Proteins/biosynthesis | 2 | 0.0 |
Zinc Fingers | 2 | 0.0 |
Microfilament Proteins/genetics | 2 | 7.0 |
Muscle Proteins/genetics | 2 | 2.0 |
Mutagenesis, Site-Directed | 5 | 0.0 |
Transcription, Genetic/*physiology | 2 | 1.0 |
Drosophila melanogaster/genetics | 3 | 3.0 |
Ectoderm/metabolism | 2 | 8.0 |
Gene Expression Regulation, Developmental | 4 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 4 | 0.0 |
NF-kappa B/physiology | 2 | 2.0 |
*Signal Transduction | 5 | 0.0 |
Trans-Activators/physiology | 2 | 1.0 |
Transcription Factor AP-1/physiology | 2 | 4.0 |
Cytoskeleton/drug effects/*metabolism | 2 | 10.0 |
Forskolin/pharmacology | 2 | 0.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
*Apoptosis | 2 | 0.0 |
Enzyme Activation | 3 | 0.0 |
NF-kappa B/*metabolism | 5 | 0.0 |
Recombinant Proteins | 2 | 0.0 |
Genes, fos/genetics | 9 | 18.0 |
Substrate Specificity | 3 | 0.0 |
Enzyme Activation/drug effects | 2 | 0.0 |
*Gene Expression Regulation/drug effects | 5 | 2.0 |
Tetradecanoylphorbol Acetate/pharmacology | 5 | 0.0 |
3T3 Cells | 21 | 1.0 |
Carrier Proteins/*metabolism | 2 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 3 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 2 | 0.0 |
Analysis of Variance | 2 | 0.0 |
Plasmids | 8 | 0.0 |
*Trans-Activators | 3 | 0.0 |
Transcription Factors | 2 | 2.0 |
Hamsters | 2 | 0.0 |
Oligonucleotide Probes | 3 | 0.0 |
Protein Biosynthesis | 4 | 0.0 |
*Gene Expression Regulation, Viral | 3 | 1.0 |
Serum Response Element/*genetics | 2 | 100.0 |
DNA-Binding Proteins/*genetics/*metabolism | 3 | 2.0 |
Nuclear Proteins/*genetics/*metabolism | 5 | 13.0 |
Oligodeoxyribonucleotides/metabolism | 3 | 6.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 2 | 0.0 |
*Mitogen-Activated Protein Kinases | 3 | 0.0 |
Serine/metabolism | 2 | 0.0 |
CCAAT-Enhancer-Binding Proteins | 3 | 1.0 |
Enhancer Elements (Genetics) | 6 | 1.0 |
DNA-Binding Proteins/genetics | 3 | 0.0 |
In Vitro | 8 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Transcription Factors/genetics | 3 | 0.0 |
Wound Healing/*physiology | 2 | 3.0 |
GTP Phosphohydrolases/metabolism | 2 | 1.0 |
GTP-Binding Proteins/metabolism | 2 | 0.0 |
Models, Biological | 4 | 0.0 |
Transcription Factors/metabolism | 11 | 0.0 |
Consensus Sequence | 6 | 0.0 |
Fibroblasts/cytology/metabolism | 2 | 1.0 |
Gene Expression Regulation/*genetics | 2 | 1.0 |
Nuclear Proteins/genetics | 2 | 0.0 |
*Repressor Proteins | 3 | 0.0 |
Transcription Factors/genetics/*metabolism | 6 | 0.0 |
Gene Expression Regulation/drug effects | 3 | 0.0 |
MAP Kinase Kinase 1 | 2 | 1.0 |
Protein Kinases/metabolism | 2 | 0.0 |
Cell Differentiation/genetics | 2 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
Mutagenesis | 4 | 0.0 |
DNA/*metabolism | 6 | 1.0 |
Mesoderm/metabolism | 3 | 3.0 |
Sequence Deletion | 3 | 0.0 |
*Zinc Fingers | 2 | 0.0 |
DNA, Complementary | 5 | 0.0 |
Tissue Distribution | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Proto-Oncogene Proteins c-fos/*genetics | 4 | 16.0 |
*Regulatory Sequences, Nucleic Acid | 3 | 0.0 |
Escherichia coli/genetics | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Recombinant Proteins/metabolism | 4 | 0.0 |
Genomic Library | 2 | 0.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Xenopus | 2 | 0.0 |
AGAMOUS Protein, Arabidopsis | 2 | 100.0 |
Nuclear Proteins/genetics/metabolism | 3 | 1.0 |
Trans-Activation (Genetics)/genetics | 2 | 2.0 |
Chickens | 4 | 0.0 |
Fibroblasts/cytology | 2 | 0.0 |
Myocardium/cytology/*metabolism | 2 | 4.0 |
Transcription Factors/*genetics | 6 | 0.0 |
Clone Cells | 2 | 0.0 |
*Nucleic Acid Conformation | 2 | 2.0 |
Peptide Mapping | 3 | 0.0 |
Protein Conformation | 3 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 3 | 1.0 |
Enzyme Activation/physiology | 2 | 1.0 |
Epidermal Growth Factor/pharmacology | 3 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Kinetics | 8 | 0.0 |
Ribosomal Protein S6 Kinases | 2 | 8.0 |
*Saccharomyces cerevisiae Proteins | 6 | 0.0 |
Cell Extracts | 3 | 2.0 |
Amino Acid Motifs | 3 | 0.0 |
*Enhancer Elements (Genetics) | 7 | 2.0 |
Proto-Oncogene Proteins c-fos | 7 | 12.0 |
Actins/*biosynthesis | 2 | 22.0 |
*Protein Biosynthesis | 2 | 0.0 |
TATA Box | 6 | 1.0 |
Muscles | 2 | 20.0 |
Repetitive Sequences, Nucleic Acid | 4 | 0.0 |
Restriction Mapping | 3 | 0.0 |
Species Specificity | 4 | 0.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 3 | 0.0 |
DNA/genetics/*metabolism | 2 | 2.0 |
Genetic Vectors | 2 | 0.0 |
DNA/genetics/metabolism | 3 | 0.0 |
Gene Expression Regulation/*physiology | 2 | 0.0 |
Fibroblasts | 2 | 0.0 |
Actins/*biosynthesis/*genetics | 2 | 66.0 |
Chloramphenicol O-Acetyltransferase/biosynthesis | 2 | 1.0 |
*Genes, ras | 2 | 0.0 |
Oligodeoxyribonucleotides | 5 | 0.0 |
*Transcription, Genetic/drug effects | 3 | 2.0 |
Xenopus laevis | 3 | 0.0 |
Genes, fos/*immunology | 2 | 66.0 |
DNA/genetics | 4 | 0.0 |
Sequence Analysis | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 4 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 4 | 0.0 |
Binding, Competitive | 7 | 0.0 |
Saccharomyces cerevisiae/genetics | 3 | 0.0 |
Transcription, Genetic/genetics | 2 | 0.0 |
Gene Expression Regulation, Developmental/*genetics | 2 | 2.0 |
Sequence Homology | 2 | 0.0 |
DNA-Binding Proteins/*metabolism/physiology | 2 | 5.0 |
Mitogen-Activated Protein Kinase 3 | 3 | 0.0 |
PC12 Cells | 2 | 0.0 |
Trans-Activation (Genetics)/*physiology | 3 | 2.0 |
*Transcription Factors, TFII | 3 | 2.0 |
*Proto-Oncogene Proteins | 5 | 0.0 |
Casein Kinase II | 2 | 1.0 |
beta-Galactosidase/genetics/metabolism | 2 | 3.0 |
Protein Kinase C/*metabolism | 2 | 0.0 |
Multigene Family | 2 | 0.0 |
Proto-Oncogene Proteins/genetics | 2 | 0.0 |
Nuclear Proteins/isolation & purification/*metabolism | 3 | 10.0 |
Transcription Factors/isolation & purification/*metabolism | 4 | 7.0 |
Muscles/*metabolism | 2 | 2.0 |
Nuclear Proteins/*pharmacology | 2 | 18.0 |
*Genes, Homeobox | 2 | 0.0 |
Oligodeoxyribonucleotides/chemistry | 4 | 1.0 |
Receptors, Interleukin-2/*genetics | 2 | 7.0 |
Regulatory Sequences, Nucleic Acid/genetics | 2 | 2.0 |
DNA-Binding Proteins/isolation & purification/*metabolism | 3 | 4.0 |
Heart/*physiology | 2 | 3.0 |
Nuclear Proteins/physiology | 2 | 2.0 |
Nuclear Proteins/*genetics/metabolism | 3 | 2.0 |
DNA-Binding Protein, Cyclic AMP-Responsive | 4 | 16.0 |
*Immediate-Early Proteins | 2 | 0.0 |
DNA-Binding Proteins/physiology | 2 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
*Proto-Oncogenes | 3 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 2 | 0.0 |
Methylation | 3 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Hela Cells/metabolism | 2 | 1.0 |
Serum Response Factor/*physiology | 2 | 100.0 |
Proto-Oncogene Proteins c-fos/genetics/metabolism | 2 | 7.0 |
Histone Deacetylases/*metabolism | 2 | 1.0 |
Serum Response Element | 2 | 33.0 |
Trans-Activation (Genetics)/drug effects | 2 | 0.0 |
Promoter Regions (Genetics)/drug effects/physiology | 2 | 6.0 |
Down-Regulation | 2 | 0.0 |
Recombinant Proteins/chemistry/genetics/metabolism | 2 | 0.0 |
MAP Kinase Signaling System/drug effects | 2 | 2.0 |
Serum Response Element/*physiology | 2 | 40.0 |
Trans-Activators/*genetics/*metabolism | 2 | 5.0 |
Homeodomain Proteins/chemistry/genetics/metabolism/*physiology | 2 | 66.0 |
rhoA GTP-Binding Protein/*metabolism | 2 | 3.0 |
